Purdue Pharma Enters Guilty Plea In Connection With Opioid Crisis

Purdue Pharma has entered a guilty plea to three federal felony charges in connection with the opioid crisis.


The U.S. Department of Justice on Wednesday announced a series of actions related to the plea, including a federal settlement worth more than $8 billion, dissolution of the company and reorganizing Purdue Pharma as a public benefit company.


The Sackler family, who own the company who makes OxyCotin, are not exempt from criminal liability, and a related investigation continues.


Purdue Pharma will plead guilty to counts of conspiracy to defraud the United States and violating federal anti-kickback laws. The company is admitting to falsely stating it had an effective anti-diversion program as well as making payments to doctors to write prescriptions of Purdue’s opioid drugs.


Purdue Pharma will have to pay a $3.5 billion criminal fine and $2 billion in criminal forfeiture. Money will also go toward assisting drug treatment programs.


4 views